Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fipaxalparant in Diffuse Cutaneous Systemic Sclerosis
NCT01651143Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of fipaxalparant in diffuse cutaneous systemic sclerosis (dcSSc), sponsored by Sanofi. Started Jan 2013; status: completed.
02
Drugs
fipaxalparant
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT01651143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651143.